ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2101

HLA Associations in Mothers of Children with Cardiac Manifestations of Neonatal Lupus

Hannah C. Ainsworth1, Carl D. Langefeld1, Miranda C. Marion2, Nathalie Costedoat-Chalumeau3, Antonio Brucato4, Jill P. Buyon5 and Robert M. Clancy5, 1Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 2Biostatistical Sciences and Center for Public Health Genomics, Wake Forest University Health Sciences, Winston-Salem, NC, 3Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 4Internal Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy, 5Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: autoimmune diseases, family studies, genetics, human leukocyte antigens (HLA) and neonatal lupus

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Genetics, Genomics and Proteomics

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:
Cardiac manifestations of neonatal lupus, comprising atrioventricular
conduction defects and cardiomyopathy, occur in fetuses exposed to anti-Ro/SSA
antibodies, and carry substantial mortality. There is strong evidence of a
genetic contribution to the risk (sibling
recurrence risk ratio is ~3,000).
Previously, in a case-control genome-wide association study, we reported that
the 17 strongest associations were within the Human Leukocyte Antigen (HLA)
region. Meisgen (2013) further underscored the potential importance of the HLA
region when they observed two-digit classic HLA associations using family-based
tests. Here, we report the first large-scale investigation of four-digit
classic HLA associations in mothers with cardiac neonatal lupus (CNL) diagnosed
children.

Methods:
Parent-CNL-affected-offspring (n = 182) trios of European ancestry were
genotyped using the Illumina Immunochip single nucleotide polymorphism (SNP) array
and merged with 1073 non-lupus out-of-study controls (635 female). Admixture
estimates were computed using ADMIXTURE. Classic four-digit HLA alleles in HLA-A,
-B, -C, -DPB1, -DQA1, -DQB1, and –DRB1
were imputed using high-quality SNPs
and the software HIBAG. Analyses were computed on HLA alleles with a best guess
allele count of at least 10 in cases or controls. Association analyses of CNL
mothers vs non-lupus female controls were computed using logistic regression,
adjusting for admixture. Transmission/disequilibrium tests (TDT) were computed using
best guess HLA alleles to test for differential transmission to affected
offspring.

Results:
A total of 119 unique HLA alleles met quality control and allele frequency
standards.  Six HLA alleles met genome-wide significance: A*01:01(3.10, 1.47×10-12),
B*08:01(7.40, 2.56×10-24), C*07:01(4.28, 1.27×10-17),
DQA1*05:01(8.22, 8.80×10-26), DQB1*02:01(8.47, 6.03×10-26),
and DRB1*03:01(8.91, 1.03×10-26) and four additional alleles met an
HLA bonferoni threshold of 0.05/119=0.00042: DQA1*01:01(0.15,1.35 x10-5),
 DQA1*03:01(0.15, 1.00 x10-4), DQB1*05:01(0.21, 1.41×10-5),
and DRB1*01:01(0.11, 9.61×10-5). To consider the joint effects
across HLA genes, stepwise modeling was computed (Table).

 

 

Allele Frequency

Single-allele

Stepwise

HLA-allele

Cases

Controls

P-value

OR (94% CI)

P-value

B*08:01

0.382

0.121

2.56E-24

2.50 (1.41-4.45)

1.84E-03

DQB1*04:02

0.037

0.022

1.65E-01

6.32 (2.49-16.00)

1.02E-04

DQB1*06:02

0.189

0.132

3.60E-03

4.00 (2.57-6.23)

8.71E-10

DRB1*03:01

0.408

0.121

1.03E-26

7.98 (4.26-14.96)

8.94E-11

DRB1*11:01

0.061

0.046

2.42E-01

5.01 (2.17-11.60)

1.66E-04

None of
the HLA alleles in the multilocus model exhibited differential transmission to
offspring via a TDT (p>0.15). In addition, none of the 119 HLA alleles
showed statistically significant evidence of differential transmission to the
offspring after adjusting for multiple comparisons.

Conclusion:
These analyses demonstrate the importance of the HLA region in mothers of CNL
children. However, the four-digit classic HLA allele associations found in the
mothers of CNL children were not differentially transmitted to the offspring.
These results suggest that the maternal HLA profile contributes to an
environment (e.g., anti-Ro antibodies) that increases the risk for CNL.

 


Disclosure: H. C. Ainsworth, None; C. D. Langefeld, None; M. C. Marion, None; N. Costedoat-Chalumeau, None; A. Brucato, None; J. P. Buyon, Bristol-Myers Squibb, 2; R. M. Clancy, None.

To cite this abstract in AMA style:

Ainsworth HC, Langefeld CD, Marion MC, Costedoat-Chalumeau N, Brucato A, Buyon JP, Clancy RM. HLA Associations in Mothers of Children with Cardiac Manifestations of Neonatal Lupus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/hla-associations-in-mothers-of-children-with-cardiac-manifestations-of-neonatal-lupus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-associations-in-mothers-of-children-with-cardiac-manifestations-of-neonatal-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology